CorrespondenceUpdosing of secukinumab to every 2 weeks results in superior efficacy in patients with severe psoriasis weighing 90 kg or more: a real-world prospective observational study.
- Published in:
- Clinical & Experimental Dermatology, 2023, v. 48, n. 7, p. 793, doi. 10.1093/ced/llad035
- By:
- Publication type:
- Article